Back
Sarepta Therapeutics Vs. Regeneron Pharmaceuticals Industry Stock Comparison
Sell
49
SRPT
Sarepta Therapeutics
Last Price:
$37.29
Seasonality Move:
12.58%
Sell
39
REGN
Regeneron Pharmaceuticals
Last Price:
$521.77
Seasonality Move:
9.53%
Sell
49
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $37.81. The Score for SRPT is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Regeneron Pharmaceuticals (REGN)
is a Sell
Is Regeneron Pharmaceuticals a Buy, Sell or Hold?
-
The current Regeneron Pharmaceuticals [REGN] share price is $518.60. The Score for REGN is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
REGN is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $37.81Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
REGN Stock Price Chart
What is Regeneron Pharmaceuticals's stock price today?
-
The Regeneron Pharmaceuticals share price today is $518.60Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and REGN is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.78 | Sell |
Relative Strength Index (14 RSI): | 38.88 | Sell |
Chaikin Money Flow: | -2241721 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (36.35 - 39.73) | Sell |
Bollinger Bands (100): | (44.55 - 105.49) | Sell |
REGN Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -22.16 | Sell |
Relative Strength Index (14 RSI): | 42.32 | Sell |
Chaikin Money Flow: | -570578 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (507.74 - 598.54) | Sell |
Bollinger Bands (100): | (559.43 - 689.97) | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.37 | Sell |
20-day SMA: | 38.44 | Sell |
50-day SMA: | 47.63 | Sell |
200-day SMA: | 100.07 | Sell |
8-day EMA: | 39.16 | Sell |
20-day EMA: | 40.5 | Sell |
50-day EMA: | 50.9 | Sell |
200-day EMA: | 88.45 | Sell |
REGN Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 499.95 | Buy |
20-day SMA: | 552.11 | Sell |
50-day SMA: | 567.54 | Sell |
200-day SMA: | 770.2 | Sell |
8-day EMA: | 516.35 | Buy |
20-day EMA: | 538.15 | Sell |
50-day EMA: | 573.35 | Sell |
200-day EMA: | 717.69 | Sell |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.74 per share, an increase next quarter of $0.95 per share, a decrease this year of $3.92 per share, and an increase next year of $7.74 per share.
Regeneron Pharmaceuticals Earnings Growth & REGN Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $1.42 per share, a decrease next quarter of $0.05 per share, a decrease this year of $9.47 per share, and an increase next year of $4.72 per share.
Sarepta Therapeutics Technical Analysis
May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Regeneron Pharmaceuticals Technical Analysis
May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | Jun 10 | Jun 11 | |
---|---|---|---|---|---|---|---|---|---|---|
May | Jun | |||||||||
29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |